Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review
Biomolecules · 2026
DOI: 10.3390/biom16101409 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Yelizaveta A Marakhovskaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Russian Gerontology Research and Clinical Centre, Pirogov Russian National Research Medical University (Pirogov University), Moscow 129226, Russia. Hauptthemen laut MEDLINE: Atherosclerosis, NLR Family, Pyrin Domain-Containing 3 Protein, Interleukin-1beta, Biological Products. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Atherosclerosis is an age-related immune-metabolic disease in which lipid retention, endothelial dysfunction, innate immune activation, and vascular remodeling interact over decades. In older adults, inflammaging, mitochondrial dysfunction, defective autophagy/mitophagy, and cellular senescence may lower the threshold for persistent inflammasome activation in the vascular wall. The NLR family pyrin domain containing 3 (NLRP3) inflammasome and interleukin-1β (IL-1β) are central to this process because they convert sterile danger signals, including cholesterol crystals, oxidized lipids, mitochondrial stress, and disturbed flow, into caspase-1 activation, IL-1β and interleukin-18 (IL-18) maturation, pyroptosis, endothelial dysfunction, macrophage activation, and plaque destabilization. Clinical proof-of-concept from IL-1β blockade supports inflammatory targeting in atherosclerotic cardiovascular disease, but direct cytokine inhibition leaves upstream inflammasome-prone states insufficiently addressed. This narrative review synthesizes evidence published from 2010 to 2026, together with older landmark studies, on mechanistic, translational, and clinical links between the NLRP3/IL-1β axis and age-related atherosclerosis. Traditional Chinese medicine-derived formulas and isolated natural compounds are considered because they may modulate upstream priming, mitochondrial reactive oxygen species, autophagy, lipid handling, macrophage polarization, endothelial pyroptosis, and inflammasome-associated cytokine release. However, most data remain preclinical, and translation requires stronger causal validation, chemical standardization, pharmacokinetic characterization, age-relevant models, and systematic safety assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Russian Gerontology Research and Clinical Centre, Pirogov Russian National Research Medical University (Pirogov University), Moscow 129226, Russia.
ORCID-Profile: Yelizaveta A Marakhovskaya, Alexey V Churov
Förderung
- Russian Science Foundation
Zitieren
APA
Marakhovskaya, Y. A., Eruslanova, K. A., Maltseva, O. N., Wu, Z., & Churov, A. V. (2026). Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review. Biomolecules. https://doi.org/10.3390/biom16101409
Vancouver
Marakhovskaya YA, Eruslanova KA, Maltseva ON, Wu Z, Churov AV. Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review. Biomolecules. 2026. doi:10.3390/biom16101409
BibTeX
@article{Marakhovskaya2026,
author = {Marakhovskaya, Yelizaveta A and Eruslanova, Ksenia A and Maltseva, Olga N and Wu, Zhengzhi and Churov, Alexey V},
title = {Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16101409}
}
EUVIMED